Pfm Health Sciences, LP Alkermes Plc. Transaction History
Pfm Health Sciences, LP
- $1.95 Billion
- Q2 2024
A detailed history of Pfm Health Sciences, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 205,073 shares of ALKS stock, worth $5.65 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
205,073
Previous 429,573
52.26%
Holding current value
$5.65 Million
Previous $11.6 Million
57.5%
% of portfolio
0.25%
Previous 0.57%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$801 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$551 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$395 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$303 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$254 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.52B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...